NUTRA PHARMA CORP.: 10-K filed 2021-07-01

Name: NUTRA PHARMA CORP.: 10-K filed 2021-07-01
Creator: NUTRA PHARMA CORP.

What NUTRA PHARMA CORP. reported in its annual report filed 2021-07-01 (fiscal FY 2019): 34 published measures, 70 facts as tagged in accession 0001493152-21-015860.

This filing

Form: 10-K (annual report)
Filed: 2021-07-01
Fiscal period: fiscal FY 2019
Accession: 0001493152-21-015860 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NUTRA PHARMA CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit
At 2019-12-31	339,832	USD
At 2019-01-02	422,592	USD
At 2018-12-31	141,417	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit
At 2019-12-31	12,040,867	USD
At 2019-01-02	6,359,185	USD
At 2018-12-31	6,078,010	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2019-12-31	-11,701,035	USD
At 2018-12-31	-5,936,593	USD
At 2017-12-31	-5,410,194	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2019-01-01 to 2019-12-31	-6,591,442	USD	365
2018-01-01 to 2018-12-31	-3,884,695	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2019-01-01 to 2019-12-31	-743,659	USD	365
2018-01-01 to 2018-12-31	-999,949	USD	365

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

Period	Value	Unit	Days
2019-01-01 to 2019-12-31	104,393	USD	365
2018-01-01 to 2018-12-31	130,596	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2019-01-01 to 2019-12-31	743,659	USD	365
2018-01-01 to 2018-12-31	999,949	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2019-12-31	-67,864,284	USD
At 2018-12-31	-61,272,842	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2019-12-31	6,763	USD
At 2018-12-31	10,500	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2019-01-01 to 2019-12-31	71,500	USD	365
2018-01-01 to 2018-12-31	70,000	USD	365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2019-01-01 to 2019-12-31	-1,229,893	USD	365
2018-01-01 to 2018-12-31	-1,878,862	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2019-12-31	57,806	USD
At 2018-12-31	115,367	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2019-12-31	10,989,633	USD
At 2018-12-31	6,026,600	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2019-12-31	583,226	USD
At 2018-12-31	475,409	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2019-12-31	32,479	USD
At 2018-12-31	17,065	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2019-01-01 to 2019-12-31	1,264,608	USD	365
2018-01-01 to 2018-12-31	1,892,924	USD	365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2019-12-31	8,177	USD
At 2018-12-31	35,302	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2019-01-01 to 2019-12-31	34,715	USD	365
2018-01-01 to 2018-12-31	14,062	USD	365

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2019-01-01 to 2019-12-31	1,202,819	USD	365
2018-01-01 to 2018-12-31	1,387,454	USD	365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2019-12-31	5,876,746,111	shares
At 2018-12-31	4,046,746,110	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2019-12-31	50,283,503	USD
At 2018-12-31	51,286,503	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2019-12-31	207,530	USD
At 2019-01-02	281,175	USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Period	Value	Unit	Days
At 2019-12-31	216,600	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2019-12-31	216,033	USD
At 2018-12-31	216,033	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2019-12-31	209,270	USD
At 2018-12-31	205,533	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2019-12-31	612,547	USD
At 2018-12-31	831,849	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2019-12-31	17,150	USD
At 2018-12-31	63,000	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2019-01-01 to 2019-12-31	-6,591,442	USD	365
2018-01-01 to 2018-12-31	-3,884,695	USD	365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2019-01-01 to 2019-12-31	3,737	USD	365
2018-01-01 to 2018-12-31	5,963	USD	365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2019-01-01 to 2019-12-31	-5,361,549	USD	365
2018-01-01 to 2018-12-31	-2,005,833	USD	365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2019-01-01 to 2019-12-31	661	USD	365
2018-01-01 to 2018-12-31	5,425	USD	365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2019-01-01 to 2019-12-31	18,203	USD	365
2018-01-01 to 2018-12-31	1,922	USD	365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2019-01-01 to 2019-12-31	25,058	USD	365
2018-01-01 to 2018-12-31	15,160	USD	365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2019-01-01 to 2019-12-31	107,817	USD	365
2018-01-01 to 2018-12-31	86,567	USD	365

Inspect the source

Entity: NUTRA PHARMA CORP. / CIK 0001119643
Captured: 2026-09-20T05:24:45.365Z
SEC response SHA-256: a9ccf17d1b07544de23a6dd72641e83d2b0b8f34b5c47b58fd5a236f1c887339

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001119643.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))